Analytical validation of a point-of-care plasma free haemoglobin method [descriptive label — exact article title VERIFICATION REQUIRED]

Certainty
Moderate
Chapters

29

Clinical implication

The interesting clinical range is 11 to 50 mg/dL and the assay concordance was established only above it. Before a unit builds a protocol around sub-threshold haemolysis it must know its own assay's performance in that band — a written question for the laboratory, not the perfusion team.

Comparator

Established laboratory methods

Design
Physiological study
Identifier

Baud B, Dupuy AM, Zozor S, Badiou S, Bargnoux AS, Mathieu O, Cristol JP. Bioanalysis 2023;16(2):65-74. DOI 10.4155/bio-2023-0116

Intervention

Point-of-care plasma free haemoglobin measurement

Limitations

Analytical study, not a clinical outcome study; device-specific

Link
Main result

Within-run imprecision under 3 percent, with acceptable concordance with laboratory methods established FROM 50 mg/dL upward. Agreement below the ELSO threshold was not established.

Population

Method-comparison study of a point-of-care free haemoglobin device against laboratory reference methods

Verified
Year
2023